Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Sprinklr
CXM
$1.65B
| $2.08M | ﹤0.01% |
+119,085
| New | +$2.22M |
|
|
TAST
3327
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $2.08M | ﹤0.01% |
568,063
-25,172
| -4% | -$112K |
|
|
CARM
3328
DELISTED
Carisma Therapeutics
CARM
| $2.08M | ﹤0.01% |
131,050
-11,478
| -8% | -$551K |
|
3329
Enterprise Products Partners
EPD
$82.1B
| $2.07M | ﹤0.01% |
95,848
-676
| -0.7% | -$15.4K |
|
|
ALPN
3330
DELISTED
Alpine Immune Sciences Inc
ALPN
| $2.07M | ﹤0.01% |
194,021
+2,483
| +1% | +$22.9K |
|
3331
Pixelworks
PXLW
$45.7M
| $2.07M | ﹤0.01% |
36,083
+3,417
| +10% | +$173K |
|
|
ONCR
3332
DELISTED
Oncorus, Inc.
ONCR
| $2.07M | ﹤0.01% |
221,601
-26,751
| -11% | -$305K |
|
3333
British American Tobacco
BTI
$124B
| $2.06M | ﹤0.01% |
58,537
-8,726
| -13% | -$328K |
|
|
OTRK
3334
DELISTED
Ontrak
OTRK
| $2.06M | ﹤0.01% |
2,285
+691
| +43% | +$1.23M |
|
3335
Applied Optoelectronics
AAOI
$11B
| $2.06M | ﹤0.01% |
287,473
+1,531
| +0.5% | +$11.3K |
|
3336
Dream Finders Homes
DFH
$1.35B
| $2.06M | ﹤0.01% |
119,007
+16,781
| +16% | +$349K |
|
|
VWTR
3337
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $2.06M | ﹤0.01% |
181,010
+2,273
| +1% | +$29.8K |
|
|
VIA
3338
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.06M | ﹤0.01% |
40,383
-1,437
| -3% | -$79.7K |
|
3339
Rio Tinto
RIO
$160B
| $2.06M | ﹤0.01% |
30,777
-587
| -2% | -$45.8K |
|
|
QCLS
3340
Q/C Technologies Inc
QCLS
$22.5M
| $2.06M | ﹤0.01% |
95
+5
| +6% | +$89.7K |
|
|
ZEV
3341
DELISTED
Lightning eMotors, Inc.
ZEV
| $2.05M | ﹤0.01% |
11,981
+1,290
| +12% | +$207K |
|
|
KLDO
3342
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $2.04M | ﹤0.01% |
374,601
+35,296
| +10% | +$219K |
|
|
ACB
3343
Aurora Cannabis
ACB
$235M
| $2.04M | ﹤0.01% |
29,483
+166
| +0.6% | +$11.8K |
|
|
SEMR
3344
DELISTED
Semrush
SEMR
| $2.04M | ﹤0.01% |
88,303
+4,617
| +6% | +$106K |
|
3345
Bankwell Financial Group
BWFG
$542M
| $2.02M | ﹤0.01% |
68,850
+1,559
| +2% | +$45.4K |
|
3346
DHI Group
DHX
$174M
| $2.02M | ﹤0.01% |
425,479
+8,681
| +2% | +$34.1K |
|
3347
Information Services Group
III
$250M
| $2.02M | ﹤0.01% |
282,142
| – | – |
|
|
TERN
3348
DELISTED
Terns Pharmaceuticals
TERN
| $2.01M | ﹤0.01% |
193,336
+50,267
| +35% | +$521K |
|
3349
Willis Lease Finance
WLFC
$1.15B
| $2.01M | ﹤0.01% |
162,537
-822
| -0.5% | -$10.8K |
|
|
FLNT
3350
Fluent
FLNT
$132M
| $2.01M | ﹤0.01% |
147,859
-3,954
| -3% | -$59.4K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.